Biophytis S.A. (BPTSY)

Market Cap	2.30M
Revenue (ttm)	n/a
Net Income (ttm)	-18.82M
Shares Out	n/a
EPS (ttm)	-13.86
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5
Open	4.60
Previous Close	n/a
Day's Range	4.60 - 5.37
52-Week Range	4.54 - 56.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 17, 2024

About Biophytis

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics targets and activates key biological resilience pathways that can protect against and counteract the effects of the multiple biological and environmental stresses, including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company’s lead drug candidate is BIO101, an ora...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 22
• Stock Exchange: OTCMKTS
• Ticker Symbol: BPTSY

Financial Performance

Financial numbers in EUR